Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5661337 | Pancreatology | 2016 | 11 Pages |
Abstract
Monitoring immune cells along with the determination of their functional capacity provides a comprehensive assessment as a prerequisite for a personalized immunotherapeutic PDAC treatment.
Keywords
ADCCrIL-2N-BPTregPBMCsγδ T cellsPancreatic ductal adenocarcinomaPDAC یا pancreatic ductal adenocarcinomaaminobisphosphonatesHuman leukocyte antigenHLAhealthy donorRecombinant interleukin-2Immune therapyPancreatic cancerperipheral blood mononuclear cellsNK cellsNatural killer cellsRegulatory T cellsImmune escapeImmune status
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Hans-Heinrich Oberg, Evelin Grage-Griebenow, Sabine Adam-Klages, Elfi Jerg, Matthias Peipp, Christian Kellner, Domantas Petrick, Daniel Gonnermann, Sandra Freitag-Wolf, Christoph Röcken, Thorsten Sebens, Ilka Vogel, Thomas Becker, Michael Ebsen,